HOP La Pitié Salpêtrière

Paris 75651

0 studies enrolling now · 7 studies all time

What they study most

Alzheimer Disease, Heart Failure, Lupus Nephritis, Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis (NASH)

Studies at this site

• Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
• A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed
• Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH — Completed
• Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo — Completed
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed